Press Releases
Trophos initiates phase II proof of concept study for...
Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announces...
Press Releases
Hybrigenics’ specific inhibitor of Ubiquitin-Specific Protease 7 (USP7) is...
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments against proliferative diseases, today...
Press Releases
Cytheris to present interim data from ECLIPSE II Hepatitis...
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim...
Press Releases
Trophos hosts round-table meetings at ECTRIMS to design POC...
Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced...
Press Releases
CertiVox wins prestigious 2011 Bully Awardsis
CertiVox, an information security company, today announces it has received the Yearling category of the 2011 Bully Award, an honour presented by White Bull Summits...
Press Releases
TxCell presents final positive results of the phase I/II...
TxCell SA, a biotechnology company developing Treg cell-based immunotherapies for the treatment of severe chronic inflammatory diseases with high unmet medical needs, announces today...
Press Releases
Taconic and Oncodesign announce agreement to co-promote and co-develop...
Taconic, a leading provider of life sciences solutions, and Oncodesign(R), an innovative leader in the discovery of novel anti-cancer therapies, announce today that they have...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.